The Swiss multinational healthcare company Roche, a global biotech giant, has expressed its eagerness to serve more cancer and rare disease patients in Bangladesh. Having been in the country for more than three decades, the drugmaker sees more prospects for the country to progress towards a stronger commitment to non-communicable disease care.